Statement by the Board of Directors in relation to the withdrawal of the public cash offer by Advent and GIC
The Board of Directors remains fully committed to Sobi and Sobi’s strategy Håkan Björklund, Chairman of the Board of Directors: “We are as committed as ever to helping people with rare diseases. The Board and I have confidence in Sobi’s vision: To be recognised as a global leader in rare diseases. We have taken important steps towards this vision in recent years, and we are proud of the clear progress made. We have a strong belief in Sobi’s strategy and the opportunities ahead. Sobi’s strategy is clear, and we are confident that the company will continue to focus and deliver on the